Photodynamic therapy (PDT) offers a cancer treatment modality capable of providing minimally invasive localized tumor necrosis. To accurately predict PDT treatment outcome based on pre-treatment patient specific parameters, an explicit dosimetry model is used to calculate apparent reacted 1 ] rx, sd ) for type-II PDT photosensitizers. Inputs into the model include a number of photosensitizer independent parameters as well as photosensitizer specific photochemical parameters ξ, σ, and β. To determine the specific photochemical parameters of benzoporphyrin derivative monoacid A (BPD), mice were treated with BPD-PDT with varied light source strengths and treatment times. All photosensitizer independent inputs were assessed pre-treatment and average necrotic radius in treated tissue was determined post-treatment. Using the explicit dosimetry model, BPD specific ξ, σ, and β photochemical parameters were determined which estimated necrotic radii similar to those observed in initial BPD-PDT treated mice using an optimization algorithm that minimizes the difference between the model and that of the measurements. Photochemical parameters for BPD are compared with those of other known photosensitizers, such as Photofrin. The determination of these BPD specific photochemical parameters provides necessary data for predictive treatment outcome in clinical BPD-PDT using the explicit dosimetry model.
INTRODUCTION
Photodynamic therapy is a cancer treatment option which utilizes light and a photosensitizing agent 1 The explicit dosimetry model is designed to account for the three traditional PDT elements of oxygen concentration, light fluence rate, and drug concentration in treated tissue 4 . In addition to drug concentration, specific photosensitizers show individualized energy transfer properties resulting in various treatment efficacies. In the model utilized the three main photochemical parameters are ξ, σ, and β. These parameters are uses to describe various ratios of intersystem energy transfers. Though there is a significant variety of PDT photosensitizers utilized for various treatments and conditions many photosensitizer photochemical parameters remain unknown. Determining the photochemical specific parameters of BPD remains significant to improve dose measurement and better determine treatment outcome in BPD approved eye, skin, and pancreatic treatments 5 .
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The patien was injecte prepared fo patient via The condensed equations (9-11) and radial light distribution profile of equation (8) were solved using the finite element method and software described in [3] . Parameters ξ, σ, and β are expected to be variable depending on the photochemical used. Other parameters used in the model, including δ and g, were not altered when fitting necrotic radii to parameters was performed.
Treatment Parameters
An initial set of treatments were tested to gain an understanding of approximate ranges of treatment times and powers which would prove useful in ascertaining photochemical parameters of BPD. After the initial experiments were performed ξ, σ, and β parameters were fitted to the measured necrotic radii. A [ [3] for Photofrin is not believed to be photosensitizer dependent and should be observed in BPD-PDT treatment. Measured vs. predicted necrotic radii profiles were created using varied ξ, σ, and β parameters.
With initial photochemical parameters established for BPD simulations were run to predict BPD-PDT efficacy. Mean μ a , μ s ', and [BPD] from the first set of treatments were used as inputs in predicting treatment efficacy for the second set of treatments. Table 2 : Data from initial round of BPD-PDT treatments. Mice with an * next to their number represent those whose average necrotic radius infringed on the radius of the tumor, not providing a clean view of the necrotic radius produced by the treatment.
RESULTS AND DISCUSSION

Initial Experiment
Using this data parameters for ξ, σ, and β were fitted to produce a [ 1 O 2 ] rx vs. necrotic radii and predicted vs.
observed necrotic radii profile. Once the fitting model was able to produce parameters in the approx. range of those of photofrin 3 and have predicted similar to observed necrotic radii parameters were manually adjusted in order to have the observed and predicted necrotic radii be closer together. The following figure shows the resultant profiles of the initial experiment after parameters were determined.
The three photochemical parameters for BPD were initially fitted as: ξ=0.023, σ=8.4 -6 , and β=11.9 to best represent the predicted necrotic radii of the model to come closest to the actual necrotic radii at a ( 1 O 2 ) rx,sd =0.42 mM.
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Predictions for Follow-up Experiment
Based on the initial experiment, supplementary treatment times and source strengths were evaluated to provide additional data for evaluating photochemical parameters consistent with BPD necrotic radii. Seventeen mice were treated at generally lower treatment times and source powers in order to decrease the possibility of the necrotic radii infringing on the tumor edge. Three control mice were used and thirteen mice were evaluated for PDT effect. Table 3 : Computed predictions for necrotic radius of mice under assumptions of average μ a, μ s ', and BPD concentration from mice in first set of treatments.
Mouse
Comparison with other Photosensitizers
The ξ, σ, and β parameters analyzed in this study are expected to be consistent on scales of orders of magnitude with those of Photofrin analyzed in [3] . All ξ values referenced in [3] , including the value fitted in the paper, span a range of approximately 10 -3 -10 -2 . The value for BPD is expected to be on the higher end of that range due to the [ ] ⁄
of Photofrin and BPD being approximately equal as none of these factors are photosensitizer dependent, S Δ is expected to be the same for BPD and Photofrin, and the ( ) for each photosensitizer has been evaluated as similar [6, 7] . With the extinction coefficient for BPD measured at approximately 10x greater than that of Photofrin, the ξ value is expected as approx. 10x greater than that of Photofrin at approx. 2x10 -3 [3] .
The σ value, based on [ ] not being photosensitizer dependent and various photosensitizer σ values as seen in [3] in a similar range, is expected to be in the 10 -5 -10 -4 range.
CONCLUSIONS AND FUTURE DIRECTION
Presently unavailable as an important dynamic in the creation of ( 1 O 2 ) rx profiles, and evaluation of appropriate ξ and σ values for the mice in the follow-up experiments are in vivo BPD concentrations for the follow-up experiment. Initial extractions of BPD concentrations provided unlikely values and were not used. Experimental BPD concentrations are being corrected based on the optical properties of the tumor tissue and refitting of the initial BPD photochemical parameters can be done. With BPD concentrations accounted for refitting of predicted tumor necrotic radii will be performed. With refitted necrotic radii, the relationship between measured and predicted necrotic radii will be evaluated and photochemical parameters will be optimized.
